COVID-19 Impact & Summary, Regions of Market Influence, and What to Watch For Long-Term
It’s like buying 10 reports in one. This volume provides readers with in vitro diagnostic market sizing and forecasting in every area of the IVD industry. Publishing in August 2023, the 16th edition of The Worldwide Market for In Vitro Diagnostic Tests is a 1500+ page report based on vendor reporting, interviews, vendor activities, and more on a global scale. This dynamic market is projected to grow over the next five years, and this resource describes all of the ways that will happen, which areas are hot and cold, and which companies stand to benefit.
For Two Decades, One Volume Has Offered Complete Coverage of the IVD Industry
The 16th edition of the Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry. Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 16th edition of the Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety.
Every significant test category in IVD is given a chapter with sub-segments. It’s like having ten market research reports in one.
Published since 1999, this 1,500+ page report is based on vendor reporting, interviews, vendor activities, and more on a global scale. This full assessment of the IVD diagnostic market makes The Worldwide Market for In Vitro Diagnostics Tests the most trusted report by top companies in the industry.
The report has complete IVD market research sections with test segment estimates and forecasts in: Clinical Chemistry, Hematology, Histology, Company Profiles and Rankings, Molecular, Immunoassay, Infectious Disease, Coagulation, Blood Bank IVD, and Point of Care. This is a very significant segment in in vitro diagnostics.
The Worldwide Market for In Vitro Diagnostic Tests is the result of months of analysis and review of secondary sources by seasoned analysts, critical readings of current and historic company filings and releases, interviews with relevant experts and searching of government sources and journal literature. All test segments contain valuable information on current market size and future projection. Compound annual growth rate is provided, as well as significant IVD companies in the market and IVD manufacturer’s product innovations. This detailed look at the IVD market yields unparalleled global market modeling.
Why The Worldwide Market for In Vitro Diagnostic Tests?
- Maximum Value: One Report, All Segments, World Markets
- Published Since 1999, by an Expert Firm That Focuses on IVD and Related Healthcare
- Profiles of 300+ Companies in the Market, Detail on the Top 40
- Filled with Industry-Utilized and Business Planning Numbers
- Learn Who is Launching Products and Investing in the IVD Industry
- Overall IVD Markets for Every Significant Nation, Detail for Major Markets
- Based on Latest Financial Reporting, Real-World Industry and Medical Practice Trends
This report gives you definitive answers to important questions, including:
- What is the Size of IVD Market Segments?
- Within Those Segments, How Do They Break Down?
- Where Will Those Markets be In Five Years?
- How Has the IVD Market Changed Over Time?
- Who’s Winning?
- Who’s Merged?
- Who’s Launched Game-Changing Products?
- What is the Competitive Landscape?
- Who Can I Partner With?
- Where are the Growth Markets I Can Enter or Buy Into?
- And More…
The most essential report on the IVD industry, The Worldwide Market for In Vitro Diagnostic Tests, is a must-have tool for understanding the IVD market on a deeper level.
Country-Level Coverage
The in vitro diagnostics market is a global one, and this report reflects the international scope of the in vitro diagnostic market’s size. In the healthcare market, IVD companies sell globally and think globally.
The 16th edition features the overall IVD market size for every significant world country, as well as details for major market segments.
Trends in one part of the world affect IVD manufacturers’ product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:
- US
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Netherlands
- Turkey
- Poland
- Canada
- China
- Japan
- Malaysia
- Singapore
- South Korea
- Australia
- Saudi Arabia
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- South Africa
- Eastern Europe
- Emerging Markets
- Rest of World
The Worldwide Market for In Vitro Diagnostic Tests is a testament to the analyst's methodology. It is the result of months of painstaking work by experienced IVD industry analysts, who have tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinions, observations and insights of industry experts to produce an unparalleled vision of the current in vitro diagnostics industry.
Competitive Analysis and Corporate Profiling
The report concentrates hundreds of pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that the analyst has in the IVD market is evident in its tiering and segmentation of companies.
Profiles of IVD-relevant companies. No other resource comes close.
First tier, second-tier and specialist companies are profiled. Financial results, product launches, company history and strategic plans are analyzed in the profiles. Over 200 Profiles are included in the report.
Companies profiled include these, and many others:
- Abbott Diagnostics
- Accelerate Diagnostics, Inc.
- Altona Diagnostics
- Amoy Diagnostics Co. Ltd.
- Angle
- Arkray
- ARUP Laboratories
- Ascensia Diabetes Care Holdings AG
- Beckman Coulter
- Becton Dickinson (BD)
- BGI Genomics (formerly Beijing Genome Institute)
- Binding Site Group Ltd. (The)
- Biocartis
- Biocept, Inc.
- Biohit
- Biomerica Inc.
- bioMerieux
- Bio-Rad
- BioReference Laboratories
- Bio-Techne Corporation
- Biotheranostics
- Bruker
- CareDx, Inc.
- CellaVision AB
- Cepheid
- Cepheid / Danaher
- Cerner Corp.
- Copan
- Corgenix Medical Corporation
- Critical Diagnostics
- Curetis
- Cynvenio Biosystems (LungLife AI)
- Dako A/S
- Danaher
- Dexcom Inc.
- Diagnostica Stago, S.A.S.
- DIAGON Kft. Hungary
- DiaSorin
- Edico Genome (Illumina)
- Eiken Chemical Co., Ltd
- EKF Diagnostics Holdings Plc
- ELITech Group S.A.S.
- Epic Sciences
- Epigenomics AG
- ERBA Diagnostics, Inc.
- Fujirebio
- Fujirebio Diagnostics, Inc.
- Genomic Health (Exact Sciences)
- Greiner Bio-One International GmbH
- Grifols
- Guardant Health, Inc.
- Hain Lifescience GmbH
- Hologic
- Horiba Medical
- HTG Molecular Diagnostics
- Human Longevity Inc.
- Illumina
- Immucor
- Immunodiagnostic Systems (IDS)
- INOVA Diagnostics, Inc.
- Instrumentation Laboratory
- Lab Corp
- Leica Biosystems
- LifeScan Inc.
- Luminex Corporation
- Medica Corporation
- MedTest DX
- Menarini Diagnostics
- Meridian Bioscience, Inc.
- MilliporeSigma
- Mindray
- Nova Biomedical
- Perkin Elmer
- PerkinElmer, Inc. (PE)
- Qiagen
- Quest
- Quest Diagnostics
- Quidel Ortho
- Radiometer
- Randox
- Randox Laboratories Ltd.
- Rennova Health, Inc.
- Response Biomedical Corp.
- Roche Diagnostics
- SD Biosensor
- Seegene
- Sekisui Diagnostics LLC
- Shimadzu Scientific Instruments
- Siemens Healthineers
- Singulex, Inc.
- Snibe Co. Ltd.
- Sonic Healthcare
- Sysmex
- Tecan Group
- Thermo Fisher Scientific
- Tosoh Bioscience
- Trinity Biotech Plc
- Werfen
Table of Contents
Samples
LOADING...
Companies Mentioned
- Abbott Diagnostics
- Agilent Technologies
- Beckman Coulter, Inc. / Danaher
- Becton, Dickinson and Company (BD)
- bioMérieux Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Cepheid / Danaher
- Danaher Corporation
- DiaSorin S.p.A
- Grifols S.A.
- Hologic, Inc.
- Instrumentation Laboratory (IL) / Werfen
- Leica Biosystems / Danaher
- Ortho Clinical Diagnostics (QuidelOrtho)
- PerkinElmer, Inc. (PE)
- QIAGEN
- Quidel Corporation (QuidelOrtho)
- Radiometer A/S / Danaher
- Roche Diagnostics
- Siemens Healthineers (Siemens)
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Ventana Medical Systems Inc. / Roche Tissue Diagnostics
- Werfen
- ARKRAY
- GI Genomics (formerly Beijing Genome Institute)
- Cue Health
- Dexcom
- Diagnostica Stago S.A.S.
- Eiken Chemical Co., Ltd
- Exact Sciences
- Fulgent Genetics, Inc
- Fujirebio Diagnostics, Inc.
- Horizon Discovery Group plc
- Illumina
- Invitae
- Labcorp, Laboratory Corporation of America
- Luminex Corporation (DiaSorin)
- Masimo Corporation
- Medtronic plc
- Meridian Bioscience, Inc.
- Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
- Natera
- Myriad Genetics, Inc.
- Philips (Royal Philips)
- Quest Diagnostics
- Randox Laboratories Ltd.
- Theradig
- Thermo Fisher Scientific Inc.
- Ventana Medical Systems Inc. / Roche Tissue Diagnostics
- Berry Genomics Co. ltd.
- CooperGenomics (Division of CooperSurgical)
- INEX Innovate
- Oxford Gene Technology
- Sequenom, Inc. (Integrated Genetics)
- Yourgene Health
- 23andMe
- Agendia BV
- Ambry Genetics
- ARUP Laboratories
- Aspira Women’s Health (formerly Vermillion Inc.)
- BioReference Laboratories
- Biotheranostics
- BluePrint Genetics Oy
- Boston Heart Diagnostics
- CareDx, Inc.
- Helomics Corporation
- Mayo Clinic Laboratories
- MDxHealth SA
- OPKO Diagnostics
- Sonic Healthcare
- Veracyte, Inc.